Explosion at Olainfarm plant injures two; Pricey packaging gets Sanofi no points in India;

> Arnprior, Canada-based Pillar5 Pharma will use a $2.5 million development grant to expand its capacity to manufacture sterile eye-care products, which will allow it to add 50 jobs. Item

> Germany-based Gerresheimer will expand a plant in the Czech Republic to fill a new order from Sanofi ($SNY) for components for insulin pens. Report

> The FDA has published new guidance laying out the reasons that antibiotics and penicillin must not be manufactured in the same facility. Report

> Two workers were injured when a vapor leak caused an explosion at the Olainfarm pharmaceutical plant in Olaine, Latvia, affecting production on two lines. Story

And Finally... An Indian court has turned back Sanofi's ($SNY) contention that it should be able to push beyond the price limit on some drugs because its counterfeit-resistant packaging is more expensive than the standard. Report